PSME3 is upregulated in pancreatic cancer cells and tissues. Upregulation of PSME3 predicts poor prognosis in pancreatic cancer. PSME3 promotes cell proliferation and invasion of pancreatic cancer. PSME3 exerts it oncogenic roles by inhibiting c-Myc degradation and thus promoting glycolysis.